Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2003-05-13
2008-09-30
Switzer, Juliet C (Department: 1634)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024310, C536S024300
Reexamination Certificate
active
07429650
ABSTRACT:
The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
REFERENCES:
patent: 5563035 (1996-10-01), Weigel
patent: 6162606 (2000-12-01), Raam
patent: 2003/0207380 (2003-11-01), Saito et al.
patent: WO 95/11995 (1995-05-01), None
patent: WO/99/58675 (1999-11-01), None
Garcia et al. (PNAS USA 1992, vol. 89, pp. 11538-11542).
GenBank record NM—018086,Homo sapiensfidgetin (FIGN) mRNA, Nov. 18, 2006.
GenBank record AF173235,Polyxenus fasciculatus18S ribosomal RNA gene, Nov. 4, 2005.
GenBank record X90668,P. lagurusgene for 18S ribosomal RNA, Jun. 6, 2003.
Cox et al. Nature Genetics, vol. 26, Oct. 2000, pp. 198-202.
GenBank record AF184588,Jonopsidium acauleLEAFY protein (LEAFY1) gene, Oct. 1, 1999.
American Journal of Botany 87(5):634-641, 2000.
Greene et al. (Science 231 (4742) 1150-1154 (1986)).
Burstein, Nelson A.; Overall Principles of Cancer Management—Hormone Therapy; published in Cancer, A Manual for Practitioners (American Cancer Society Massachusetts Division); 6th Edition, 1982, pp. 67-71.
Donegan, William L.; Prognostic Factors; Cancer 1992; 70:1755-1764.
Brooks, S. C., et al.; Relation of Tumor Content of Estrogen and Progesterone Receptors with Response of Patient to Endocrine Therapy; Cancer 46:2775-2778, 1980.
Degenshein, George A., et al.; The Value of Progesterone Receptor Assays in the Management of Advanced Breast Cancer; Cancer 46:2789-2793, 1980.
Fuqua, Suzanne A. W., et al.; Variant Human Breast Tumor Estrogen Receptor with Constitutive Transcriptional Activity; Cancer Research 51:105-109, Jan. 1, 1991.
Gelbfish, Gary A., et al.; Relationship of Estrogen and Progesterone Receptors to Prognosis in Breast Cancer; Ann Surg. 207(1):75-79, Jan. 1998.
Greene, Geoffrey, et al.; Sequence and Expression of Human Estrogen Receptor Complementary DNA; Science vol. 231, pp. 1150-1154: Mar. 7, 1986.
Kohail, Hanaa M., et al.; A Multifactorial Analysis of Steroid Hormone Receptors in Stages I and II Breast Cancer; Ann. Surg 201(5):611-617, May 1985.
Elledge, Richard M., et al.; Prognostic Factors and Therapeutic Decisions in Axillary Node-Negative Breast Cancer; Annu. Rev. Med. 1993, 44:201-210.
McGuire, William L.; Prognostic factors for recurrence and survival in human breast cancer; Breast Cancer Research and Treatment 10:5-9, 1987.
Millis, Rosemary R.; Correlation of Hormone Receptor with Pathological Features in Human Breast Cancer; Cancer 46:2869-2871, 1980.
McCarty, Kenneths, et al.; Correlation of Estrogen and Progesterone Receptors with Histologic Differentiation in Mammary Carcinoma; Cancer 46:2851-2858, 1980.
O'Connell, Peter, et al.; Loss of Heterozygosity at D14S62 and Metastatic Potential of Breast Cancer; Reports, Journal of the National Cancer Institute, vol. 91(16), pp. 1391-1397; Aug. 18, 1999.
Shousha, S., et al.; Oestrogen receptors in mucinous carcinoma of the breast: an immunohistological study using paraffin wax sections; J. Clin. Pathol. 1989; 42:902-905.
Shousha, S., et al.; Immunohistological study of oestrogen receptors in breast carcinomas that are biochemically receptor negative; J. Clin. Pathol. 1990; 43:239-242.
Williams, M. R., et al.; Oestrogen receptors in primary and advanced breast cancer: An eight year review of 704 cases; Br. J. Cancer (1987), 55:67-73.
Vogelstein, Bert, et al.; The multistep nature of cancer; TIG vol. 9 (4), pp. 138-141, Apr. 1993.
Weigel, Ronald, J., et al.; Transcriptional Control of Estrogen Receptor in Estrogen Receptor-negative Breast Carcinoma; Cancer Research, vol. 53 (15):3472-3474, Aug. 1, 1993.
Scott, Gary K., et al.; Truncated Forms of DNA-binding Estrogen Receptors in Human Breast Cancer; J. Clin. Invest. 1991, 88:700-706.
Ince, B. Avery, et al.; Powerful Dominant Negative Mutants of the Human Estrogen Receptor; The Journal of Biological Chemistry, vol. 268 (19), 14026-14032, 1993.
Fuqua, Suzanne A. W., et al.; Inhibition of Estrogen Receptor Action by a Naturally Occurring Variant in Human Breast Tumors; Cancer Research 52:483-486, Jan. 15, 1992.
Castles, Carl G., et al.; Expression of a Constitutively Active Estrogen Receptor Variant in the Estrogen Receptor-negative BT-20 Human Breast Cancer Cell Line: Cancer Research 53 (24):5934-5939, Dec. 15, 1993.
Keaveney, M., et al.; Evidence for a Previously Unidentified Upstream Exon in the Human Oestrogen Receptor Gene; J. Mol. Endocr., vol. 6:111-115, 1991.
Piva, R., et al.; Sequencing of an RNA Transcript of the Human Estrogen Receptor Gene: Evidence for a New Transcriptional Event; J. Steroid Biochem. Molec. Biol., 46 (5), pp. 531-538, 1993.
McDonnell, Donald P., The Molecular Pharmacology of SERMs, TEM, vol. 10 (8):301-311, 1999.
Barkhem, Tomas, et al.; Differential Response of Estrogen Receptor a and Estrogen Receptor B to Partial Estrogen Agonists/Antagonists; Molecular Pharmacology, 54:105-112, 1998.
Sun, Jun, et al.; Novel Ligands that Function as Selective Estrogens or Antiestrogens for Estrogen Receptor-a or Estrogen Receptor-B; Endocrinology, vol. 140 (2):800-804, 1999.
Barkhem, Tomas, et al.; Characterization of the “Estrogenicity” of Tamoxifen and Raloxifene in HepG2 Cells: Regulation of Gene Expression from an ERE Controlled Reporter Vector Versus Regulation of the Endogenous SHBG and PS2 Genes; J. Steroid Biochem. Molec. Biol., vol. 62 (1), pp. 53-64, 1997.
Cowley, Shaun, M., et al.; Estrogen Receptors a and B Form Heterodimers on DNA; The Journal of Biological Chemistry, vol. 272 (32), pp. 19858-19862, Aug. 8, 1997.
Paige, Lisa A., et al.; Estrogen receptor (ER) modulators each induce distinct conformational changes in ER a and ER B; Proc. Natl. Acad. Sci. USA, vol. 96, pp. 3999-4004, Mar. 1999.
Shiau, Andrew K., et al.; The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen; Cell, vol. 95, pp. 927-937, Dec. 28, 1998.
Cowley, Shaun M., et al.; A comparison of transcriptional activation by ERa and ERB; Journal of Steroid Biochemistry and Molecular Biology, vol. 69, pp. 165-175, 1999.
Tremblay, Gilles B., et al.; Cloning, Chromosomal Localization, and Functional Analysis of the Murine Estrogen Receptor B; Molecular Endocrinology 11:353-365, 1997.
Witkowska, H. Ewa, et al.; Characterization of bacterially expressed rat estrogen receptor B ligand binding domain by mass spectrometry; Structural comparison with estrogen receptor a; Steroids 62:621-631, 1997.
McGuire, William L., et al.; Estrogen Receptor Variants in Clinical Breast Cancer; Molecular Endocrinology 5:1571-1577, 1991.
van Agthoven, Ton, et al.; Differential Expression of Estrogen, Progesterone, and Epidermal Growth Factor Receptors in Normal, Benign, and Malignant Human Breast Tissues using Dual Staining Immunohistochemistry; American Journal of Pathology, vol. 144 (6), pp. 1238-1246, Jun. 1994.
Zhang, Ziu-Xia, et al.; An Estrogen Receptor Mutant with Strong Hormone-independent Activity from a Metastatic Breast Cancer; Cancer Research 57:1244-1249, Apr. 1, 1997.
Tremblay, Gilles B., et al.; Ligand-independent Activation of the Estrogen Receptors a and B by Mutations of a Conserved Tyrosine Can Be Abolished by Antiestrogens; Cancer Research 58:877-881, Mar. 1, 1998.
Anandappa, Shanez Y., et al.; Variant estrogen Receptor a mRNAs in Human Breast Cancer Specimens; Int. J. Cancer: 88, pp. 209-216, 2000.
Schuur, Eric R., et al.; Monoallelic Amplification of Estrogen Receptor-a Expression in Breast Cancer; Cancer Research 60, pp. 2598-2601, May 15, 2000.
Fasco, Michael J., et al.; Expression of an estrogen receptor alpha variant protein in cell lines and tumors; Molecular and Cellular Endocrinology 162, pp. 167-180, 2000.
Rost, Natalia S., et al.; Immunochemical analyses of estrogen receptors in human breast tumors by a novel monoclonal estrogen receptor antibody (EVG F9);
Allred D. Craig
Fuqua Suzanne
Hopp Torsten A.
O'Connell Peter
Baylor College of Medicine
Fulbright & Jaworski LLP
Switzer Juliet C
LandOfFree
Methods and compositions in breast cancer diagnosis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions in breast cancer diagnosis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions in breast cancer diagnosis and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3982480